Abstract A99: Phase I trial of veliparib or mitomycin C + veliparib in pts with Fanconi anemia pathway (FA) repair defects. Conference

Villalona-Calero, Miguel A, Duan, Wenrui, Zhao, Weiqiang et al. (2011). Abstract A99: Phase I trial of veliparib or mitomycin C + veliparib in pts with Fanconi anemia pathway (FA) repair defects. . MOLECULAR CANCER THERAPEUTICS, 10(11_Supplement), a99-a99. 10.1158/1535-7163.targ-11-a99

cited authors

  • Villalona-Calero, Miguel A; Duan, Wenrui; Zhao, Weiqiang; Gao, Li; Thurmond, Jennifer; Leon, Marino; Shilo, Konstantin; De Fiore, Tricia; Westman, Judith A; Ji, Jay; Zhang, Yiping; Marshall, John; Rose, Jeff; Bekaii-Saab, Tanios; Chen, Alice; Otterson, Gregory

authors

publication date

  • November 12, 2011

published in

keywords

  • 32 Biomedical and Clinical Sciences
  • 3202 Clinical Sciences
  • 3211 Oncology and Carcinogenesis
  • 6.1 Pharmaceuticals
  • Breast Cancer
  • Cancer
  • Clinical Research
  • Clinical Trials and Supportive Activities
  • Genetics
  • Orphan Drug
  • Ovarian Cancer
  • Rare Diseases
  • Women's Health

Digital Object Identifier (DOI)

publisher

  • American Association for Cancer Research (AACR)

start page

  • a99

end page

  • a99

volume

  • 10

issue

  • 11_Supplement